A tilt-detector for the Xal-Ease eye drops delivery aid. Usability and patient satisfaction.

A tilt-detector for the Xal-Ease eye drops delivery aid. Usability and patient satisfaction. - E-Box & Xal-Ease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32758

Enrollment

Registered

2010-02-04

Start date

2010-03-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma/ocular hypertension

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Informed consent. - Age > 18 years. - Glaucoma or ocular hypertension. - Use of Xalatan for IOP reduction.

Exclusion criteria

Exclusion criteria: - IOP reducing surgery. - Auditory impairment.

Design outcomes

Primary

Measure	Time frame
Part 1: Ratio of correctly administered fluorescein drops. Part 2: Treatment satisfaction score.	—

Secondary

Measure	Time frame
IOP	—

Countries

Netherlands

Outcome results